By contrast we did not see changes of p53 levels in CRC cells after shRNA-mediated DHPS ablation, suggesting that the observed effect could be related to the drug or the conditions used rather then to exclusive DHPS inhibition. Here, DHPS is linked to colorectal carcinoma.